A series of 23-hydroxybetulinic acidderivatives were prepared and tested in vitro as a new class of inhibitors of glycogenphosphorylase (GP). Within this series of compounds, 12b (IC50 = 3.5 μM) is the most potent GPa inhibitor. The preliminary SAR results of the 23-hydroxybetulinic acidderivatives are discussed.